Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : CEO Backs Booster Shots Ahead of FDA Committee Meeting

09/16/2021 | 02:35pm EDT


ę MT Newswires 2021
All news about PFIZER, INC.
10:12aToday on Wall Street: It’s a numbers game
09:38aWORLD PRESS REVIEW : October 27, 2021
07:00aPRESS RELEASE : BioNTech to Report Third Quarter Financial Results and Operational Update ..
DJ
06:59aBristol Myers reports 10% quarterly sales growth as cancer drugs rebound
RE
06:26aThermo Fisher lifts full-year forecast after third-quarter profit beat
RE
05:06aCovid-19 - Unpacking South Africa's Plan to Vaccinate Adolescents
AQ
04:11aEUROPEAN MIDDAY BRIEFING - Stocks Fall After -3-
DJ
04:00aGSK names Johns Hopkins scientist to board ahead of consumer unit spinoff
RE
10/26Swissmedic OKs Pfizer/BioNTech COVID-19 Booster Jabs For High Risk People
MT
10/26Pfizer, BioNTech Get US FDA Panel's Endorsement for COVID-19 Vaccine in Children 5 and ..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 557 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,8x
Yield 2021 3,62%
Capitalization 244 B 244 B -
EV / Sales 2021 3,35x
EV / Sales 2022 3,82x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 43,56 $
Average target price 45,72 $
Spread / Average Target 4,96%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.17.22%244 227
JOHNSON & JOHNSON5.32%436 334
ROCHE HOLDING AG15.84%338 387
NOVO NORDISK A/S60.69%244 467
ELI LILLY AND COMPANY47.15%225 231
MERCK & CO., INC.0.55%208 206